<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="the spectrum of their indications, and identify drug combinations for" exact="treatment" post="of emerging and re-emerging viral infections. Abstract Viral diseases"/>
 <result pre="the spectrum of their indications, and identify drug combinations for" exact="treatment" post="of emerging and re-emerging viral infections as well as"/>
 <result pre="Finally, we discuss future perspectives of using safe-in-man BSAAs for" exact="treatment" post="of emerging and re-emerging viral infections as well as"/>
 <result pre="HIV-1 LTR promoter allowed quantitation of BSAA action on HIV-1" exact="infection" post="(tat-protein expression by integrated HIV-1 provirus) using firefly luciferase"/>
 <result pre="assays as well as CRISPR-Cas9 systems could be used for" exact="detection" post="of inhibitory effects of BSAAs (Boonham et al., 2014,"/>
 <result pre="repurposing BSAAs, given that drug concentrations and duration of the" exact="treatment" post="could be different, and therefore, drug safety issues should"/>
 <result pre="Japan; cidofovir is an injectable antiviral medication used as a" exact="treatment" post="for CMV retinitis in people with AIDS; ribavirin, also"/>
 <result pre="with AIDS; ribavirin, also known as tribavirin, is used for" exact="treatment" post="of RSV and HCV infections; pleconaril is used against"/>
 <result pre="further pre-clinical and clinical investigations. BSAAs as drug candidates for" exact="treatment" post="of SARS-CoV-2 infections SARS-CoV-2 is a novel strain of"/>
 <result pre="No vaccines and drugs are available for prevention, prophylaxis and" exact="treatment" post="of coronavirus infections in humans (Eurosurveillance Editorial, 2020). However,"/>
 <result pre="teicoplanin, oritavancin, dalbavancin, monensin and emetine could be repurposed for" exact="treatment" post="of COVID-19. Teicoplanin, ritavancin, dalbavancin and monensin are approved"/>
 <result pre="Moreover, chloroquine and remdesivir were shown to effectively inhibit SARS-CoV-2" exact="infection" post="in vitro. In addition, clinical investigations into the effectiveness"/>
 <result pre="lopinavir/ritonavir (Kaletra), ledipasvir/sofosbuvir and sofosbuvir/velpatasvir) became a standard for the" exact="treatment" post="of HIV or HCV infections. Several synergistic drug combinations,"/>
 <result pre="obatoclax/saliphenylhalamide and gemcitabine/pimodivir, could enter clinical studies and become effective" exact="treatment" post="of ZIKV and FLUAV infections (Fu et al., 2016,"/>
 <result pre="of nitazoxanide, favipiravir, and niclosamide could be developed for the" exact="treatment" post="of viruses belonging to 11 families. Other activities of"/>
 <result pre="withdrawn). These agents with dual activity could be used for" exact="treatment" post="of viral and bacterial co-infections or for the protection"/>
 <result pre="development of broad-spectrum anti-infective drugs. BSAAs could also serve as" exact="treatment" post="of other co-morbidities, therefore, simplifying the therapy and lowering"/>
 <result pre="concomitant actions of ezetimibe and statins could be beneficial for" exact="treatment" post="of both hypertension and several viral infections in patients"/>
 <result pre="rescues microcephaly in a humanized in vivo model of Zika" exact="infection" post="using human induced neural stem cellsBiol Open72018 CarterM.ShiehJ.Chapter 14"/>
 <result pre="3-deazaadenosineAntiviral Res3198317246307139 de GraafM.HerfstS.SchrauwenE.J.van den HoogenB.G.OsterhausA.D.FouchierR.A.An improved plaque reduction virus" exact="neutralization assay" post="for human metapneumovirusJ Virol Methods143200716917417420056 DeansR.M.MorgensD.W.OkesliA.PillayS.HorlbeckM.A.KampmannM.Parallel shRNA and CRISPR-Cas9"/>
 <result pre="Valley fever virusJ Gen Virol8920082157216618753225 HaeseN.N.BroeckelR.M.HawmanD.W.HeiseM.T.MorrisonT.E.StreblowD.N.Animal models of Chikungunya virus" exact="infection" post="and diseaseJ Infect Dis2142016S482S48727920178 HowardC.R.FletcherN.F.Emerging virus diseases: can we"/>
 <result pre="pluripotent stem cellsInt J Mol Sci202019 JangY.ShinJ.S.YoonY.S.GoY.Y.LeeH.W.KwonO.S.Salinomycin inhibits influenza virus" exact="infection" post="by disrupting endosomal acidification and viral matrix protein 2"/>
 <result pre="antiviral effectsPLoS Pathog82012e1002976 KaoJ.C.HuangFuW.C.TsaiT.T.HoM.R.JhanM.K.ShenT.J.The antiparasitic drug niclosamide inhibits dengue virus" exact="infection" post="by interfering with endosomal acidification independent of mTORPLoS Negl"/>
 <result pre="frameVirology3242004677315183054 KobanR.NeumannM.DaugsA.BlochO.NitscheA.LanghammerS.A novel three-dimensional cell culture method enhances antiviral drug" exact="screening" post="in primary human cellsAntiviral Res1502018202929224735 KonigA.YangJ.JoE.ParkK.H.P.KimH.ThanT.T.Efficient long-term amplification of"/>
 <result pre="Res1502018202929224735 KonigA.YangJ.JoE.ParkK.H.P.KimH.ThanT.T.Efficient long-term amplification of hepatitis B virus isolates after" exact="infection" post="of slow proliferating HepG2-NTCP cellsJ Hepatol71201928930031077792 KuivanenS.BespalovM.M.NandaniaJ.IanevskiA.VelagapudiV.De BrabanderJ.K.Obatoclax, saliphenylhalamide"/>
 <result pre="cellsJ Hepatol71201928930031077792 KuivanenS.BespalovM.M.NandaniaJ.IanevskiA.VelagapudiV.De BrabanderJ.K.Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus" exact="infection" post="in vitro and differentially affect cellular signaling, transcription and"/>
 <result pre="transcription and metabolismAntiviral Res139201711712828049006 LaamiriN.AouiniR.MarnissiB.GhramA.HmilaI.A multiplex real-time RT-PCR for simultaneous" exact="detection" post="of four most common avian respiratory virusesVirology5152018293729223788 LandryM.L.Nucleic acid"/>
 <result pre="in human dendritic cellsScience34320141246980 LiC.DengY.Q.WangS.MaF.AliyariR.HuangX.Y.25-Hydroxycholesterol protects host against Zika virus" exact="infection" post="and its associated microcephaly in a mouse modelImmunity46201744645628314593 LouzD.BergmansH.E.LoosB.P.HoebenR.C.Animal"/>
 <result pre="MacGibenyM.A.KoyuncuO.O.WirblichC.SchnellM.J.EnquistL.W.Retrograde axonal transport of rabies virus is unaffected by interferon" exact="treatment" post="but blocked by emetine locally in axonsPLoS Pathog142018e1007188 MandellL.A.WunderinkR.G.AnzuetoA.BartlettJ.G.CampbellG.D.DeanN.C.Infectious"/>
 <result pre="and Tokay geckoVision Res719672432515613294 MontoyaM.C.KrysanD.J.Repurposing estrogen receptor antagonists for the" exact="treatment" post="of infectious diseaseMBio92018 MorrisonT.E.DiamondM.S.Animal models of Zika virus infection,"/>
 <result pre="domain of cellular vacuolar ATPase provides a target for the" exact="treatment" post="of influenza A virus infectionsBr J Pharmacol164201134435721418188 MullerK.H.SpodenG.A.SchefferK.D.BrunnhoferR.De BrabanderJ.K.MaierM.E.Inhibition"/>
 <result pre="Terrier, O., Rosa-Calatrava, M., 2019. Drug repurposing approaches for the" exact="treatment" post="of influenza viral infection: reviving old drugs to fight"/>
 <result pre="standardized assessments of neutralizing antibodies against HIV-1J Immunol Methods409201413114624291345 SashitalD.G.Pathogen" exact="detection" post="in the CRISPR-Cas eraGenome Med1020183229690921 SchorS.EinavS.Combating intracellular pathogens with"/>
 <result pre="GS-5734 inhibits both epidemic and zoonotic coronavirusesSci Transl Med92017 ShenL.NiuJ.WangC.HuangB.WangW.ZhuN.High-throughput" exact="screening" post="and identification of potent broad-spectrum inhibitors of coronavirusesJ Virol932019"/>
 <result pre="N.J.)10302013407425 SoderholmS.KainovD.E.OhmanT.DenisovaO.V.SchepensB.KulesskiyE.Phosphoproteomics to characterize host response during influenza a virus" exact="infection" post="of human macrophagesMol Cell Proteomics1520163203321927486199 StachulskiA.V.PidathalaC.RowE.C.SharmaR.BerryN.G.LawrensonA.S.Thiazolides as novel antiviral"/>
 <result pre="of three quantification methods for the TZM-bl pseudovirus assay for" exact="screening" post="of anti-HIV-1 agentsJ Virol Methods2332016566127016178 XuM.LeeE.M.WenZ.ChengY.HuangW.K.QianX.Identification of small-molecule inhibitors"/>
 <result pre="agentsJ Virol Methods2332016566127016178 XuM.LeeE.M.WenZ.ChengY.HuangW.K.QianX.Identification of small-molecule inhibitors of Zika virus" exact="infection" post="and induced neural cell death via a drug repurposing"/>
 <result pre="cell death via a drug repurposing screenNat Med2220161101110727571349 XuY.P.QiuY.ZhangB.ChenG.ChenQ.WangM.Zika virus" exact="infection" post="induces RNAi-mediated antiviral immunity in human neural progenitors and"/>
 <result pre="replication and decreasing viral entryCell Discov420183129872540 YinY.BijveldsM.DangW.XuL.van der EijkA.A.KnippingK.Modeling rotavirus" exact="infection" post="and antiviral therapy using primary intestinal organoidsAntiviral Res123201512013126408355 YinY.ChenS.HakimM.S.WangW.XuL.DangW.6-Thioguanine"/>
 <result pre="of Rac1 GDP/GTP cyclingAntiviral Res15620189210129920300 YinY.WangY.DangW.XuL.SuJ.ZhouX.Mycophenolic acid potently inhibits rotavirus" exact="infection" post="with a high barrier to resistance developmentAntiviral Res1332016414927468950 YoungD.D.ConnellyC.M.GrohmannC.DeitersA.Small"/>
 <result pre="Res1332016414927468950 YoungD.D.ConnellyC.M.GrohmannC.DeitersA.Small molecule modifiers of microRNA miR-122 function for the" exact="treatment" post="of hepatitis C virus infection and hepatocellular carcinomaJ Am"/>
 <result pre="microRNA miR-122 function for the treatment of hepatitis C virus" exact="infection" post="and hepatocellular carcinomaJ Am Chem Soc13220107976798120527935 ZhangY.H.ZhaoY.LiN.PengY.C.GiannoulatouE.JinR.H.Interferon-induced transmembrane protein-3"/>
 <result pre="associated with a new coronavirus of probable bat originNature2020 ZhouT.TanL.CederquistG.Y.FanY.HartleyB.J.MukherjeeS.High-content" exact="screening" post="in hPSC-neural progenitors identifies drug candidates that inhibit Zika"/>
 <result pre="in hPSC-neural progenitors identifies drug candidates that inhibit Zika virus" exact="infection" post="in fetal-like organoids and adult brainCell Stem Cell212017274–283.e275 Appendix"/>
</results>
